Sofosbuvir and Ledipasvir combo Therapy for HCV: End game for interferon?

Sofosbuvir and Ledipasvir combo Therapy for HCV: End game for interferon?

Watkins Richard R

Infectious Disease Alert

2014

2014-04

Genotype; Costs and Cost Analysis; Adverse Drug Event; Randomized Controlled Trials; Antiviral Agents – Therapeutic Use; Drug Combinations – Therapeutic Use; Hepatitis C – Drug Therapy; Hepatitis C – Epidemiology; Ribavirin – Therapeutic Use

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

73–75

7

33